ABSTRACT
tion to allow classification. 13, 14 For this study, pol was selected to allow both cladistic analysis and identification of drug resistance.
Antiretroviral therapy comprises two main classes of drug: targetting viral protease (PR) and viral reverse transcriptase (RT), often used in combination. Most resistance-conferring mutations occur in the pol gene, which constitutes the coding region for protease, reverse transcriptase, and integrase. Some commercial systems (e.g., ABI and Visible Genetics) have been developed to detect important mutations, and some reference laboratories, for example, in France and the United Kingdom, have developed in-house methodologies. 13, 15 The Caribbean Epidemiology Centre (CAREC) is a public health organization administered by the Pan American Health Organization (PAHO), WHO's regional office for the Americas. CAREC provides reference laboratory services to 21 countries in the region. 16 Consequently, CAREC has a role both in the surveillance of HIV and as a serum bank. The purpose of this study was primarily to identify which clades are currently circulating in the region and to allow evaluation of the tech-nology by CAREC/PAHO/WHO for transfer and implementation within the Caribbean, potentially allowing the continuation of surveillance including monitoring of drug therapy.
Sera from the Caribbean Epidemiology Centre (CAREC) were used, representing individuals from 10 countries, naive to antiretroviral drugs. Specimens met the following essential criteria: (1) over 300 ml per sample, received at CAREC nonhemolysed, and stored frozen at 220°C; and (2) specimens received from 2000 to 2002 were HIV positive by two different enzyme immunoasays (EIAs) (two-step sandwich EIA to detect IgM, IgG, and IgA and one-step sandwich EIA to detect both antibody and antigen simultaneously).
Ten countries were represented by the 94 samples (Table 1) : Antigua (10), Dominica (5), Grenada (4), Guyana (12), Montserrat (1), St. Lucia (7), St. Vincent (7), St. Kitts (1), Suriname (7), and Trinidad and Tobago (40), with 34 males, 54 females, and 6 of unknown gender. Ages ranged between 2 and 65 years, with a mean, median, and mode of 22 years.
RNA was extracted from serum specimens using the Qiagen Biorobot 9604 using an input of 200 ml and elution volume of 60 ml. Positive control was plasma containing 500,000 copies HIV RNA/ml. Negative control was uninfected plasma.
Reverse transcription polymerase chain reaction (RT-PCR) and sequencing were carried out as previously described, 15 except that a one-step RT-PCR protocol (Qiagen) was used.
Sequences were aligned and edited using Sequencher (Gene Codes Corporation). The Stanford University website (http://hivdb.stanford.edu/hiv) was used for subtype determination. Information on drug resistance was also provided at this site.
Seventy-one of 94 specimens yielded between 1022 and 1200 bp contiguous, overlapping sequence in both directions, comprising both protease and the upstream region of the RT gene. For eight nonamplifiable samples, for which sufficient sample was available, HIV infection was confirmed using the Fujirebio gelatin agglutination antibody test. Failure to amplify product for these samples was likely due to low viral load or nonsubtype B subtype. 17 A neighbor-joining tree was constructed using the sequence alignment generated plus reference sequences of clades B, C, and D, respectively, registered in GenBank. [18] [19] [20] The neighbor-joining tree was obtained using PAUP 4.0 (Fig. 1) , after using Modeltest 3.06 PPC to choose the most appropriate model. Subtype designation of specimens was compared with those generated from the NCBI subtyping site (http://www.ncbi.nlm.nih.gov/retroviruses/subtype/subtype.ht ml).
Sixty-seven specimens (94%) were classified as clade B using the Stanford system. Four specimens were classified as potentially non-B; of these, one (1.4%) was C with respect to both protease and RT, ID #133, and three (4.2%) were D/B, i.e., B with respect to RT and D with respect to protease sequence (ID #26, #38, and #113). Using the NCBI system and reference strains the majority of specimens were clade B (98.6%). Many of these had regions of similarity to clade D (40%), and some showed regions of similarity to other clades, specifically C, F, and G (7%). The large proportion of specimens with D-like stretches could be a result of the underrepresentation of Caribbean strains in the NCBI B clade reference database.
However, clades B and D have been shown to be closely related with respect to gag, env, and pol sequences and probably diverged relatively recently, 2, 4 Thus separation of these lineages is not as well defined as between other clades. The neighborjoining tree generated after modeling grouped these three D/B specimens with B clade viruses (Fig. 1) . Future studies, including those with an epidemiological component, could shed light on the distribution and prevalence and possibly result in more accurate classification of HIV-1 viruses, and indeed, other aspects of HIV spread in the region.
No primary drug resistance-associated mutations were detected in these samples. Some secondary mutations were identified in some specimens. However, these were exclusively natural polymorphisms that can be associated with drug resistance when present with other mutations, but do not in themselves signify problems with or previous exposure to chemotherapy. This confirms expectations that the population sampled has not been exposed to antiretroviral therapy. While it is reassuring VAUGHAN ET AL. 930 
